Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11

Tanno, Luciana Kase; Calderón, Moisés A.; Papadopoulos, Nikolaos G.; Sánchez‐Borges, Mario; Rosenwasser, Lanny J.; Bousquet, Jean; Pawankar, Ruby; Sisul, Juan Carlos; Cepeda, Alfonso; Li, James; Muraro, Antonella; Fineman, Stanley; Sublett, James; Katelaris, Constance H.; Chang, Yoon-Seok; Moon, Hee‐Bom; Casale, Thomas B.; Demoly, Pascal

doi:10.1016/j.jaip.2015.12.022

Cited by 26 publications

(11 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Meanwhile, actions to strengthen standard international definitions, notification tools, classification and coding to support obtaining more accurate morbidity and mortality 10 anaphylaxis data are ongoing. This is exemplified by the efforts taken to have an improved classification of allergic and hypersensitivity conditions in ICD-11 revision, 9,10,12,13,[21][22][23][24][25][26][27][28][29][30][31] which resulted in the construction of a pioneer section entitled "Allergic and hypersensitivity conditions," in which anaphylaxis is one of the main headings. 13,14 The construction of the new section dealing with anaphylaxis means that the latter will now be recognized as a clinical condition requiring specific documentation and management.…”

Section: Prevention Concepts Applied To Anaphylaxismentioning

confidence: 99%

Applying prevention concepts to anaphylaxis: A call for worldwide availability of adrenaline auto‐injectors

Tanno¹,

Simons

Sánchez‐Borges

et al. 2017

Clin Experimental Allergy

View full text Add to dashboard Cite

Section: Prevention Concepts Applied To Anaphylaxismentioning

confidence: 99%

Applying prevention concepts to anaphylaxis: A call for worldwide availability of adrenaline auto‐injectors

Tanno¹,

Simons

Sánchez‐Borges

et al. 2017

Clin Experimental Allergy

View full text Add to dashboard Cite

“…To create a more appropriate classification for allergic and hypersensitivity conditions in the ICD‐11, a detailed action plan was coordinated based on scientific evidences for the necessity of changes . Collaboration with the WHO ICD‐11 revision governance is ongoing so far, and all the efforts are being acknowledged by the Joint Allergy Academies.…”

Section: Differences In the Classification Of The Main Allergic And Hmentioning

confidence: 99%

Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision

Tanno

Bierrenbach

Calderón

et al. 2016

Allergy

View full text Add to dashboard Cite

show abstract

“…All the evidence‐based academic process has been documented in peer‐reviewed publications (P. Demoly , L.K. Tanno, unpublished data) 2,9,10,13,15‐39 …”

Section: The World Needs Better Health Datamentioning

confidence: 99%

Global implementation of the world health organization's International Classification of Diseases (ICD)‐11: The allergic and hypersensitivity conditions model

Tanno

Chalmers

Jacob

et al. 2020

Allergy

Self Cite

View full text Add to dashboard Cite

The International Classification of Diseases (ICD) provides a common language for use worldwide as a diagnostic and classification tool for epidemiology, clinical purposes and health management. Since its first edition, the ICD has maintained a framework distributing conditions according to topography, with the result that some complex conditions, such as allergies and hypersensitivity disorders (A/H) including anaphylaxis, have been poorly represented. The change in hierarchy in ICD‐11 permitted the construction of the pioneer section addressed to A/H, which may result in more accurate mortality and morbidity statistics, including more accurate accounting for mortality due to anaphylaxis, strengthen classification, terminology and definitions. The ICD‐11 was presented and adopted by the 72nd World Health Assembly in May 2019, and the implementation is ongoing worldwide. We here present the outcomes from an online survey undertaken to reach out the allergy community worldwide in order to peer review the terminology, classification and definitions of A/H introduced into ICD‐11 and to support their global implementation. Data are presented here for 406 respondents from 74 countries. All of the subsections of the new A/H section of the ICD‐11 had been considered with good accuracy by the majority of respondents. We believe that, in addition to help during the implementation phase, all the comments provided will help to improve the A/H classification and to increase awareness by different disciplines of what actions are needed to ensure more accurate epidemiological data and better clinical management of A/H patients.

show abstract

Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11

Cited by 26 publications

References 32 publications

Applying prevention concepts to anaphylaxis: A call for worldwide availability of adrenaline auto‐injectors

Applying prevention concepts to anaphylaxis: A call for worldwide availability of adrenaline auto‐injectors

Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision

Global implementation of the world health organization's International Classification of Diseases (ICD)‐11: The allergic and hypersensitivity conditions model

Contact Info

Product

Resources

About